PHENYLBUTAZONE SODIUM 200 mg/mL
(equivalent to PHENYLBUTAZONE 186 mg/mL base)
SODIUM SALICYLATE 50 mg/mL
Phenylbutazone is a non-steroidal anti-inflammatory and analgesic agent. Sodium salicylate is an antipyretic analgesic agent. The combination of these two drugs provides both rapid action (sodium salicylate) and prolonged effect (phenylbutazone).
For the relief of painful musculoskeletal conditions in horses. Such conditions include arthritis, arthrosis, osteitis, osteoarthritis, bursitis, tendonitis, tenosynovitis and the inflammation of soft tissues and skin.
When used for the relief of febrile conditions, treatment of the underlying cause should be provided concurrently with Platinum Bute IV Injection.
The safety of Platinum Bute IV has been evaluated at doses of up to 20 mL/225 kg (Day 1) and 10 mL/225 kg (Days 2-5), without any adverse effect.
DIRECTIONS FOR USE
RESTRAINT DO NOT USE in horses intended for human consumption.
This product is contraindicated for use in horses with serious cardiac, hepatic or renal dysfunction, history of blood disorders (especially haemoglobinuria) or gastro-intestinal disturbances.
Toxic reactions to Platinum Bute IV Injection are uncommon, but may be expressed as oedema of legs, jaundice, blood dyscrasia or gastric irritation.
Dosage and administration
Administer by slow intravenous injection of solution at room temperature.
HORSES and FOALS
Initially 5-10 mL per 225 kg per day. Subsequent doses, depending on response, may be reduced to 2.5-5 mL per 225 kg per day. Treatment should be continued for 5-6 days.
MEAT WITHHOLDING PERIOD (HORSES)
NOT TO BE USED in horses intended for human consumption.
If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126.
Dispose of empty container by wrapping with paper and putting in garbage.
Store between 2 and 8°C (Refrigerate. Do not freeze). Protect from light. Store vials in an upright position.
Following withdrawal of the first dose, use the remainder of the vial within 4 days or discard the unused portion.
APVMA Approval No. 68303/58052 (Australia)